Article: BioMedEcon Reports 200% Higher Outpatient Medical Costs among Patients with Obsessive-Compulsive Disorder Compared to Matched Patients with Depression.

Results show surprisingly higher outpatient costs in OCD group despite patient matching for medical illness comorbidity

MOSS BEACH, Calif. -- BioMedEcon, a leading provider of health economics and outcomes research, presented findings from a landmark nine-year retrospective claims analysis that compared the median per-patient health care costs for patients with obsessive-compulsive disorder (OCD) versus depression. This study, supported by Jazz Pharmaceuticals, Inc., was presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) annual meeting on May 3-7, in Toronto.

The purpose of this study was to demonstrate the comparative health ...

Related newspaper, magazine, and journal articles:

Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!